| Dana G Wilmot, RN | |
|
2600 Marble Ave Ne, Albuquerque, NM 87106-2058 | |
| (505) 999-6610 | |
| Not Available |
| Full Name | Dana G Wilmot |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 2600 Marble Ave Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053638007 | NPI | - | NPPES |
| R45523 | Other | NM | NEW MEXICO BOARD OF NURSING |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | R45523 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dana G Wilmot, RN 1532 Reynosa Loop Se, Rio Rancho, NM 87124-8751 Ph: (505) 999-6610 | Dana G Wilmot, RN 2600 Marble Ave Ne, Albuquerque, NM 87106-2058 Ph: (505) 999-6610 |
News Archive
Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement with TG United, Inc. of Brooksville, Florida, to provide commercial-scale manufacturing capabilities for reaZin. Adeona is developing reaZin, its product candidate for the dietary management of Alzheimer's disease and mild cognitive impairment, as a prescription medical food.
According to research presented at the School of Medicine and the University of Navarra Hospital by Dr. Roberto Muñoz, a physician of the Neurology Service of the Hospital Complex of Navarra, those persons with serious cases of sleep apnea have more than twice the possibility of suffering an ischemic stroke. Specifically, 2.5 times more.
Changing the order in which two drugs are taken significantly extended the lives of women with metastatic breast cancer, a study has found.
Bristol-Myers Squibb Company today announced results from the Phase IIb EMERGE clinical trial, in which treatment with the investigational compound PEG-Interferon lambda and ribavirin achieved higher rates of rapid virologic response in genotypes 1, 2, 3, and 4, and complete early virologic response in genotypes 1 and 4 than the standard regimen of PEG-Interferon alfa and ribavirin in treatment-naïve patients chronically infected with hepatitis C.
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013.
› Verified 7 days ago
Cynthia Ann Kirschenman, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1408 Windridge Dr Nw, Albuquerque, NM 87120 Phone: 605-929-5032 Fax: 505-291-2102 | |
Rosa Matonti, RN, MSN, CNS, CDE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1217 1st St Nw, Albuquerque, NM 87102 Phone: 505-681-0178 | |
Ryan Matson, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4806 Constitution Ave Ne, Albuquerque, NM 87110 Phone: 832-656-7173 | |
Pamela Clark, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6400 Uptown Blvd Ne, Ste 360w, Albuquerque, NM 87110 Phone: 505-855-9805 Fax: 505-848-9468 | |
Michelle Treme, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6400 Uptown Blvd Ne, Ste 360w, Albuquerque, NM 87110 Phone: 505-855-9805 Fax: 505-848-9468 | |
Robert William Adams, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4101 Indian School Rd Ne, Albuquerque, NM 87110 Phone: 505-256-6718 Fax: 505-256-6844 | |
Melissa Velasquez, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 933 Bradbury Dr Se, Albuquerque, NM 87106 Phone: 505-272-3120 Fax: 505-272-8060 |